Vaccine-Med
Smart Portfolio
Dear Investors, Here is your monthly update for June 2025 ✨ June was a strong month for markets, with the S&P 500 and Nasdaq-100 hitting record highs, driven by renewed tech optimism—particularly around AI and chip stocks like Nvidia and AMD. Defense and cybersecurity sectors rallied following geopolitical events in the Middle East; crude spiked to $75 before falling back to $65. The Fed and Bank of England held rates steady amid geopolitical and trade uncertainty, while the ECB cut by 25bps. The US dollar slumped, posting its worst half-year since the 1980s. In crypto, Bitcoin gained while Ethereum slipped, as the US Senate passed the GENIUS Act, laying the groundwork for stablecoin regulation. 💭 Find out more about what happened in June with eToro's Smart Portfolios Monthly summary here: etoro.turtl.co/story/etoros-investment-office-performance-report-june25 Performance Stats: @Vaccine-Med-> June: 3.23% , QTD: 4.01% YTD: -13.80% Benchmark (SGH - S&P Global 1200 Health Care Sector GICS Level 1 Index) -> June: 1.36% , QTD: -4.88% YTD: -0.10% Best Performer: $PSNL (Personalis Inc) 41.68% Worst Performer: $VLA.PA (Valneva SE) -15.71% Portfolio Indicated Dividend Yield: 0.98% Some of the assets inside the @Vaccine-Med Smart Portfolio are: $MRNA (Moderna Inc) , $PCVX (Vaxcyte Inc) , $BAVA.CO (Bavarian Nordic A/S) , $DVAX (Dynavax Technologies Corp) , $CVAC , $NVAX (Novavax Inc) , $VIR (Vir Biotechnology Inc) , $MRVI (Maravai LifeSciences Holdings Inc.) , $PSNL , $VLA.PA ❓ Check out the portfolio fact sheet by clicking the following link: bullaware.com/factsheet/Vaccine-Med This Smart Portfolio is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. Please remember past performance is not indicative of any future performance.